Karen A. Dawes - 14 Jun 2024 Form 4/A Insider Report for REPLIGEN CORP (RGEN)

Role: Director
Signature: /s/ Kenneth O'Brien (Attorney in Fact)
Issuer symbol: RGEN
Transactions as of: 14 Jun 2024
Net transactions value: $0
Form type: 4/A
Filing time: 19 Aug 2024, 19:29:25 UTC
Date Of Original Report: 14 Jun 2024
Previous filing: 20 May 2024
Next filing: 19 May 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RGEN	Common Stock						91,123	14 Jun 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4/A amends a Form 4 filed on 6/14/2024 to correct an administrative error, which misreported the number of shares beneficially owned by the reporting person. The correction reflects an increase in the number of shares beneficially owned by the reporting person by 2,953 shares. Exhibit 24.1: Power of Attorney